Takeda TSE4502NYSETAK today announced that the U.S. Food and Drug Administration FDA has approved GAMMAGARD LIQUID Immune Globulin Infusion Human 10 solution as an intravenous immunoglobulin IVIG therapy to improve neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy CIDP.
Takeda s GAMMAGARD LIQUID® Approved by U S FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Takeda s GAMMAGARD LIQUID® Approved by U S FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.